Results 51 to 60 of about 18,293 (187)

Cytologic Characteristics of Meningeal Carcinomatosis: Increased Diagnostic Accuracy Using Carcinoembryonic Antigen and Epithelial Membrane Antigen Immunocytochemistry

, 1998
BACKGROUND AND OBJECTIVES Traditionally, the diagnosis of meningeal carcinomatosis has been based on clinical suspicion and confirmed by cytologic study of cerebrospinal fluid.
Ganjei-Azar, Parvin, Jorda, Merce, Nadji, Mehrdad   +2 more
core   +1 more source

Cervical Spinal Meningeal Enhancement on Magnetic Resonance Imaging in Healthy Dogs: Characteristics of Enhancement Patterns and the Effect of Acquisition Time

Veterinary Radiology &Ultrasound, Volume 67, Issue 1, January 2026.
ABSTRACT Meningeal enhancement on magnetic resonance imaging (MRI) is commonly associated with pathological conditions, including inflammation, neoplasia, or ischemia. However, short and thin segments of contrast enhancement are considered normal in the brain meninges, but studies on spinal meningeal enhancement in dogs are limited.
Minhee Lee, Wooseok Jin, Sang‐Kwon Lee, Hojung Choi, Youngwon Lee, Miori Kishimoto, Kija Lee   +6 more
wiley   +1 more source

Guidelines for the Diagnosis and Treatment of Advanced Breast Cancer in China (2024 Edition)

Cancer Innovation, Volume 4, Issue 6, December 2025.
“The core objective of this guideline is to personalize the management of advanced breast cancer through molecular subtyping, optimizing the balance between survival and quality of life. We integrate recent evidence‐based advances and underscore the essential roles of multidisciplinary collaboration and management of patient‐reported outcomes (PROs ...
Breast Cancer Expert Committee of the National Quality Control Center for Cancer, Breast Cancer Expert Committee of the China Anti‐Cancer Association, Cancer Drug Clinical Research Committee of the China Anti‐Cancer Association   +2 more
wiley   +1 more source

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center

European Journal of Neurology, Volume 32, Issue 12, December 2025.
ABSTRACT Background Cerebrospinal fluid (CSF) analysis is key to diagnosing multiple sclerosis (MS). In particular, the presence of CSF‐specific oligoclonal bands (OCB) is examined alongside differential diagnostic aspects. This study aims to investigate the diagnostic value of OCB in MS compared to other neurological disorders.
Tobias Monschein, Benjamin Scheicher, Markus Ponleitner, Nik Krajnc, Fabian Föttinger, Tobias Zrzavy, Paulus Rommer, Barbara Kornek, Gabriel Bsteh, Thomas Perkmann, Thomas Berger, Fritz Leutmezer   +11 more
wiley   +1 more source

Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis

International Journal of Cancer, Volume 157, Issue 8, Page 1613-1624, 15 October 2025.
What's New? Leptomeningeal disease is a highly palliative condition of tumor cell seeding that can cause symptomatic hydrocephalus. This multi‐center retrospective study of patients with leptomeningeal disease‐associated hydrocephalus compared the placement of ventriculoperitoneal shunts and Rickham reservoirs for cerebrospinal fluid drainage.
Obada T. Alhalabi, Lukas Klein, David Wasilewski, Amine Mellal, Carmen Büsken, Clara Buszello, Giulia Cossu, Ilker Y. Eyüpoglu, Andreas W. Unterberg, Peter Vajkoczy, Gabriele Schackert, Mahmoud Messerer, Martin Misch, Tobias Kessler, Wolfgang Wick, Christine Jungk, Ahmed El Damaty, Sandro M. Krieg, Tareq A. Juratli, Alexander Younsi   +19 more
wiley   +1 more source

Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions

Advanced Science, Volume 12, Issue 33, September 4, 2025.
Brain metastases (BM) from lung cancer are aggressive with poor prognosis. This review covers clinical features, diagnosis, early metastasis, and multi‐omics‐elucidated mechanisms, especially the tumor microenvironment of lung cancer with BM. It also discusses preclinical models, signaling pathways, and emerging therapies.
Yixiang Zhu, Danming He, Zan Hou, Mei Lan, Ye Zhang, Qifeng Wang   +5 more
wiley   +1 more source

Pyrotinib and Nab‐Paclitaxel in HER2‐Positive Breast Cancer (PANHER Trial): A Prospective, Single‐Arm, Phase II Trial

Cancer Science, Volume 116, Issue 7, Page 1920-1929, July 2025.
In this multicenter, single‐arm, open‐label phase II trial, patients with HER2‐positive breast cancer who had previously received chemotherapy with taxanes or anthracyclines were enrolled to receive pyrotinib combined with nab‐paclitaxel, and the results demonstrated promising efficacy with an acceptable safety profile.
Huan Li, Min Yan, Zhaohui Li, Xiujie Cui, Xuening Ji, Fengqi Fang, Yuyang Zhang, Yan Wang, Xiangyu Guo, Mingxi Jing, Zhichao Gao, Hui Cao, Fangyuan Dong, Jie Wu, Cui Jiang, Yangyang Duan, Xiaorui Li, Yujun Jiang, Lei Jiang, Ying E, Yufeng Jia, Liang Zhang, Pai Peng, Tao Sun   +23 more
wiley   +1 more source

Table_1_The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis.XLSX

, 2023
ObjectiveThe objective of this research is to investigate the clinical application value of cerebrospinal fluid (CSF) cytology and circulating tumor DNA (ctDNA) in lung adenocarcinoma (LUAD) meningeal metastasis-meningeal carcinomatosis (MC), and to ...
Yan-Li Tan (14715925), Shu-Jie Cheng (14715931), Ya-Nan Chen (2823038), Yan-Hong Shang (14715928), Wei-Ying Di (14715922), Chun-Hui Li (2967243), Yun Cai (397696), Chuan Fang (11911301), Qiang Geng (426255), Ya-Nan Wang (257476)   +9 more
core   +1 more source

Meningeosis carcinomatosa [Meningeal carcinomatosis]

, 2016
BACKGROUND: The incidence of leptomeningeal involvement from carcinomas, meningeal carcinomatosis, is underestimated and often an event of advanced stages of the disease.
Bommer, M., Bullinger, L.
core   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source